# A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI

> **NCT07287852** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Hadassah Medical Organization** · enrollment: 50 (estimated)

## Conditions studied

- Alzheimer Disease (AD)
- Mild Cognitive Impairment (MCI)

## Interventions

- **DIETARY_SUPPLEMENT:** Ginkgo Biloba Extract 761

## Key facts

- **NCT ID:** NCT07287852
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-08-20
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07287852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07287852, "A Pilot Study to Examine the Effect of Egb761 on Plasma Biomarker Levels and on Cognitive Function in Patients With MCI". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07287852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*